本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Crescent Biopharma Inc

15.89
+0.34502.22%
盘后15.890.00000.00%16:57 EDT
成交量:17.11万
成交额:270.92万
市值:2.21亿
市盈率:-0.35
高:16.98
开:15.86
低:15.36
收:15.55
数据加载中...
2021/06/30

重要事件披露

8-K - Current report
2021/06/10

重要事件披露

8-K - Current report
2021/05/18

重要事件披露

8-K - Current report
2021/05/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/06

重要事件披露

8-K - Current report
2021/05/05

重要事件披露

8-K - Current report
2021/04/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/21

重要事件披露

8-K - Current report
2021/03/04

重要事件披露

8-K - Current report
2021/03/04

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/03

重要事件披露

8-K - Current report
2021/02/19

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals